ExploreWatchlistsPricing
  1. JP-listed companies
  2. DAIICHI SANKYO COMPANY, LIMITED
  3. Financials
  4. Provision for income taxes

DAIICHI SANKYO COMPANY, LIMITED (4568)

Market cap
¥5.29T
P/E ratio
17.8x
Daiichi Sankyo is a global pharmaceutical company that researches, develops and sells prescription drugs and over-the-counter medicines worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 202559,874+65.32%
Mar 31, 202436,217+105.01%
Mar 31, 202317,666+170.00%
Mar 31, 20226,543-483.75%
Mar 31, 2021-1,705-113.98%
Mar 31, 202012,196-260.66%
Mar 31, 2019-7,591-190.58%
Mar 31, 20188,380-22.91%
Mar 31, 201710,870-166.16%
Mar 31, 2016-16,430-118.15%
Mar 31, 201590,500

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat